A distinctive form of autophagy induced by oncogenic RAS

Area of Science:

• Molecular Biology
• Cancer Biology
• Cellular Biology

Background:

• RAS mutations are prevalent in cancers and promote tumor growth by enhancing autophagy.
• Understanding the specific mechanisms of RAS-induced autophagy is crucial for developing targeted therapies.
• Existing knowledge does not clearly distinguish RAS-induced autophagy from physiological autophagy.

Purpose of the Study:

• To identify and characterize a unique form of autophagy induced by RAS mutations.
• To investigate the molecular regulators and structural differences of this novel autophagy pathway.
• To evaluate the therapeutic potential of targeting this specific autophagy mechanism in RAS-mutant cancers.

Main Methods:

• Identification of RAS-induced non-canonical autophagy via ATG8ylation (RINCAA).
• Characterization of distinct autophagic factors and structures (RIMMBA) involved in RINCAA.
• Investigation of the role of ULK1-mediated PI4KB phosphorylation in RINCAA.

Main Results:

• Discovered RINCAA, a novel autophagy pathway distinct from starvation-induced autophagy.
• RINCAA utilizes unique autophagic factors and forms RAS-induced multivesicular/multilaminar bodies of ATG8ylation (RIMMBA).
• Inhibition of ULK1-mediated PI4KB phosphorylation demonstrated superior therapeutic effects compared to general autophagy inhibitors.

Conclusions:

• RAS-driven cancers utilize a unique autophagy pathway, RINCAA, which differs from canonical autophagy.
• Targeting the specific molecular events within RINCAA, such as PI4KB phosphorylation, presents a more effective therapeutic strategy than general autophagy inhibition.
• This research opens avenues for developing precision therapies for RAS-mutant cancers by targeting their specific autophagic vulnerabilities.